Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-9 of  9 results for ""ECULIZUMAB""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Electronic Resource

Eculizumab injection.

Subjects: ECULIZUMAB; PAROXYSMAL hemoglobinuria; ERYTHROCYTES

  • Source: ASHP Patient Medication Information - English Version. Mar2022, p1-1. 1p.

Record details

Read Online Read More Add to Saved list
×
News

How Much Will Soliris' 'Second Act' Bolster Alexion Stock?

Subjects: NEUROMYELITIS optica; ECULIZUMAB; THERAPEUTICSALEXION Pharmaceuticals Inc. 789359510 ALEXION Pharmaceuticals Inc. ALEXION Pharmaceuticals Inc. 789359510 789359510 ALEXION Pharmaceuticals Inc. 789359510 ALXN

  • Source: Investors Business Daily. 9/24/2018, pN.PAG-N.PAG. 1p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.

Subjects: LETTERS to the editor; PAROXYSMAL hemoglobinuria

  • Source: New England Journal of Medicine. 12/28/2006, Vol. 355 Issue 26, p2786-2788. 1p.

Record details

Read More Add to Saved list
×
News

Patients win fight to get life-saving €430k medicine.

  • Source: Daily Mail. 2/5/2015, p10. 1p.

Record details

Read Online Read More Add to Saved list
×
Electronic Resource

Serogroup B Meningococcal Vaccine (MenB).

  • Source: ASHP Patient Medication Information - English Version. Mar2022, p1-1. 1p.

Record details

Read Online Read More Add to Saved list
×
Electronic Resource

Meningococcal ACWY Vaccines (MenACWY).

  • Source: ASHP Patient Medication Information - English Version. Mar2022, p1-1. 1p.

Record details

Read Online Read More Add to Saved list
×

MarketLine Company Profile: Alexion Pharmaceuticals, Inc.

Subjects: *PHARMACEUTICAL industryUNITED StatesALEXION Pharmaceuticals Inc. 789359510 ALEXION Pharmaceuticals Inc. ALEXION Pharmaceuticals Inc. 789359510 789359510 ALEXION Pharmaceuticals Inc. 789359510 ALXN

  • Source: Alexion Pharmaceuticals, Inc. MarketLine Company Profile. 7/31/2023, p1-23. 23p.

Record details

Read Online Read More Add to Saved list
×
Periodical

This week on MIP: Huawei-Ericsson deal, senior lawyer reveals Hong Kong SAR move.

Subjects: *LAWYERSHONG Kong (China)TELEFON AB L.M. Ericsson

  • Source: Managing Intellectual Property. 9/11/2023, pN.PAG-N.PAG. 1p.

Record details

Read Online Read More Add to Saved list
×
Periodical

This week on MIP: Amgen biosimilar ban, new UPC judges.

Subjects: AMGEN Inc. 039976196 AMGEN Inc. AMGEN Inc. 039976196 039976196 AMGEN Inc. 039976196 AMGN

  • Source: Managing Intellectual Property. 8/28/2023, pN.PAG-N.PAG. 1p.

Record details

Read Online Read More Add to Saved list
×
  • 1-9 of  9 results for ""ECULIZUMAB""